Article History
Accepted: 17 December 2020
First Online: 6 February 2021
Compliance with Ethical Standards
:
: Lauren Dennison and Aditya A. Mohan declare no conflict of interest. Mark Yarchoan has received research funding from Incyte, Bristol-Myers Squibb, Exelixis, and Genentech/Roche, and has served on advisory boards for Exelixis, Eisai, AstraZeneca, and Geneos Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.